SFM
BBH icon

Signet Financial Management’s VanEck Biotech ETF BBH Stock Holding History

Signet Financial Management’s Portfolio BBH Stock Details BBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-2,586
Closed -$296K – 208
2015
Q3 		$296K Buy
2,586
+469
+22% +$62.1K 0.07% 135
2015
Q2 		$285K Sell
2,117
-475
-18% -$63.1K 0.07% 143
2015
Q1 		$336K Buy
+2,592
New +$326K 0.09% 131

Other funds holding BBH

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $14.2B AUM 20.68% 1-Year Est. Return
MCM
Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return
VFAM
Valley Forge Asset Management King Of Prussia, Pennsylvania $645M AUM 5.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Signet Financial Management's BBH Position: Q4 2015 in Review

Signet Financial Management sold out of VanEck Biotech ETF (BBH) in Q4 2015, closing a stake of 2,586 shares — an estimated $296K sold.

Signet Financial Management first reported a position in BBH in Q1 2015 and held it in 3 quarters. The position peaked at $336K in Q1 2015. 90 funds tracked by Wall St. Rank hold BBH as of Q4 2015.

  • Signet Financial Management reported no remaining VanEck Biotech ETF position as of Q4 2015 after selling out during the quarter.
  • Signet Financial Management sold 2,586 VanEck Biotech ETF shares in Q4 2015, an estimated $296K.
  • Signet Financial Management first reported a position in VanEck Biotech ETF in Q1 2015 and held it in 3 quarters.
  • Signet Financial Management's VanEck Biotech ETF position peaked at $336K in Q1 2015.
  • 90 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q4 2015.

Based on Signet Financial Management's 13F filing for Q4 2015, filed 8 Feb 2016.